home
stocks
Shilpa Medicare

100% Hold

Shilpa Medicare Share Price

Q: What is the Shilpa Medicare share price today?

Shilpa Medicare share price is Rs. 524.45 today.

Q: What is today’s high & low stock price of Shilpa Medicare?

Shilpa Medicare stock price high: Rs. 557.70 and low: Rs. 521.05

Q: What is the market capital of Shilpa Medicare shares today?

Shilpa Medicare has a market capitalization of Rs. 4,403.03 Crores.

Q: What is the Shilpa Medicare stock price high and low in the last 52 weeks on the NSE?

52 Week Stock High Price is Rs. 557.70 and Low Price is Rs. 228.50

Q: What is the Shilpa Medicare Stock Symbol?

The Shilpa Medicare Stock symbol is SHILPAMED.

Q: Can I buy Shilpa Medicare shares on Holidays?

<div class="text-sm text-gray-accent3">No, shares of Shilpa Medicare or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Shilpa Medicare shares on days when the stock exchanges are open for trading. It's important to check the <a class="text-primary-base" target="_blank" href="https://upstox.com/stocks-market/nse-holidays-2024/">NSE</a> & <a class="text-primary-base" target="_blank" href="https://upstox.com/stocks-market/bse-holidays-2024/">BSE</a> holidays calendar, before placing any trades to avoid any inconvenience.</div>

Q: Can I do stock trading on my phone?

<div class="text-sm text-gray-accent3">Yes, Upstox trading app allows you to trade easily once KYC documents are verified online. This app is available for both iOS and Android devices. For the Android app, <a class="text-primary-base" target="_blank" href="https://play.google.com/store/apps/details?id=in.upstox.app&pli=1">click here</a>, and for the iOS app, <a class="text-primary-base" target="_blank" href="https://apps.apple.com/in/app/upstox-stocks-ipo-mf/id1584953620">click here</a>.</div>

SHILPAMED

₹524.45-₹16.05 (-2.97%) Past YearLast updated on 18 Apr, 2024 | 03:59 PM IST

₹521.05₹557.70

News
Company overview
Fundamentals
Events
More

What’s in news?

Moneycontrol • 13h

Shilpa Medicare shares touch 52-week high on GMP Certification

DSIJ • 1d

Madhusudan Kela bought 8,79,121 shares & Sunil Singhania bought 6,00,000

Moneycontrol • 5d

Shilpa Medicare raises Rs 500 crore via QIP, plans for future utilisation

FinancialExpress • 1w

Shilpa Medicare board approves QIP at Rs 477/ share

Moneycontrol • 1w

Shilpa Medicare board approves QIP at floor price of Rs 477.33 per share

Livemint • 2w

Intraday trading stocks for today: Raymond to LTFH — Anand Rathi expert

Livemint • 1mo

Stock to buy: Anand Rathi picks Shilpa Medicare as stock of the month!

Moneycontrol • 2mo

Shilpa Standalone December 2023 Net Sales at Rs 63.98 crore

Moneycontrol • 4mo

Shilpa Medicare rallies 5% on TGA Australia approval to Bengaluru unit

Moneycontrol • 5mo

Shilpa Standalone September 2023 Net Sales at Rs 74.61 crore

Company overview

About

Market cap

₹4,403 Cr

Open

₹539.10

Close

₹540.50

Circuit range

₹648.60 - ₹432.40

Day range

₹521.05 - ₹557.70

Year range

₹228.50 - ₹557.70

Volume

19,15,749

Avg. traded

₹539.85

Revenue (12m)

₹1,123 Cr

Shilpa MedicareShilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in research and development, manufacturing and sale of oncology drugs and formulations. Its products consist of oncology and non-oncology active pharmaceutical ingredients (APIs), oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. It supplies oncology APIs and intermediates. Its oncology/non-oncology APIs include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib HCL, and Irinotecan HCL Trihydrate for various regulated markets, including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India. It is also engaged in manufacturing and sale of Lenvatinib Capsules under the brand name Lenshil.

52 week high

₹557.70

52 week low

₹228.50

P/E ratio

P/B ratio

2.62 ROE

-2.37%

ROCE

-1.61%

Dividend yield

--

Debt/Equity ratio

0.14 EPS

-5.7

Learn more

Featured in

Pharmaceuticals

Investment checklist: (3/6)

Equity returns

Dividend returns

Safety factor

Growth factor

Debt vs Equity

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:
Hold

Buy

Hold

100%

Sell

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

Profitability
Operational
Valuation

Operating profit margin

9.95%

Net profit margin

-19.98%

ROE

-2.37%

ROA

-1.83%

ROCE

-1.61%

Learn more

Shilpa Medicare Shareholder returns

1 day

+6.55%

1 week

+6.81%

1 month

+21.98%

3 months

+64.16%

1 year

+112.46%

3 years

+41.53%

5 years

+43.85%

Revenue statement

All values are in ₹ Crores (Cr)

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)

No data available at the moment

Shilpa Medicare Share Price history

Day	Open	Close	Day’s change
Tue, Apr 16 2024	₹503.00	₹540.50	+6.94%
Mon, Apr 15 2024	₹506.00	₹507.25	+0.25%
Fri, Apr 12 2024	₹511.00	₹505.75	-1.04%
Wed, Apr 10 2024	₹525.00	₹512.05	-2.53%
Tue, Apr 9 2024	₹506.95	₹522.65	+3.00%
Mon, Apr 8 2024	₹501.95	₹506.05	+0.81%
Fri, Apr 5 2024	₹492.00	₹495.90	+0.79%
Thu, Apr 4 2024	₹512.95	₹493.80	-3.88%